新强联(300850) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥690,513,134.83, an increase of 8.04% year-on-year, while the year-to-date revenue reached ¥1,952,873,064.65, up 2.79% compared to the previous year[6]. - Net profit attributable to shareholders for Q3 2022 was ¥91,253,720.50, a decrease of 59.38% year-on-year, with a year-to-date net profit of ¥333,712,666.12, down 16.56%[6]. - The basic earnings per share for Q3 2022 was ¥0.28, reflecting a decline of 61.11% compared to the same period last year, while the diluted earnings per share also stood at ¥0.28[6]. - The company's operating revenue for the current period was approximately 1.7 billion, a significant increase from 751.36 million in the previous period, reflecting a growth of 126.5%[42]. - The net profit for the current period was approximately 342.89 million, compared to 399.92 million in the previous period, indicating a decrease of 14.3%[40]. - The total profit for the current period was approximately 388.21 million, down from 457.91 million, a decline of 15.2%[40]. - The company's total comprehensive income for the current period was approximately 342.89 million, compared to 399.92 million in the previous period, a decline of 14.3%[40]. Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥7,925,402,848.54, representing a 26.68% increase from the end of the previous year[6]. - Current assets totaled CNY 3,899,347,863.10, a decrease from CNY 4,080,719,257.51 in the previous period, representing a decline of approximately 4.4%[34]. - Non-current assets increased to CNY 4,026,054,985.44 from CNY 2,175,639,770.45, showing a significant growth of about 85.1%[34]. - Total liabilities rose to CNY 4,125,944,106.68, up from CNY 2,748,177,163.85, marking an increase of approximately 50.2%[34]. Cash Flow - The company's cash flow from operating activities for the year-to-date period was ¥547,127,743.11, showing a significant increase of 206.76%[6]. - Operating cash flow turned positive with a net amount of ¥547,127,743.11, a 206.76% increase, attributed to increased collections and bill discounts[18]. - Net cash flow from operating activities was $547.13 million, a significant improvement from a net loss of $512.49 million in the previous period[48]. - Cash received from operating activities totaled $1.75 billion, compared to $771.61 million in the previous period[48]. - Cash paid for operating activities amounted to $1.20 billion, slightly lower than $1.28 billion in the prior year[48]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 23,198, with the top ten shareholders holding significant stakes[19]. - The largest shareholder, Xiao Zhengqiang, holds 20.14% of shares, amounting to 66,399,195 shares[19]. Investment Activities - Investment income for the year-to-date period was ¥20,250,200.05, a substantial increase of 397.44% compared to the previous year, mainly from the sale of stocks and financial products[15]. - The company recorded investment income of approximately 20.25 million, compared to 4.07 million in the previous period, a significant increase of 396.3%[40]. - Cash received from investment recoveries was $1.01 billion, a substantial increase from $200 million in the previous period[48]. Financing Activities - The company reported a 70.00% increase in share capital, reaching ¥329,708,796.00, primarily due to the conversion of capital reserves into share capital[15]. - The company experienced a 218.01% increase in short-term borrowings, totaling ¥1,747,049,879.18, attributed to an increase in financing scale[15]. - Financing cash flow decreased by 66.11% to ¥551,010,319.95, primarily due to fundraising activities in 2021[18]. - Net cash flow from financing activities was $551.01 million, a decrease from $1.63 billion in the previous year[48]. - Cash inflow from financing activities was $1.82 billion, down from $2.19 billion year-over-year[48]. Expenses - The company reported a 58.46% rise in management expenses, amounting to ¥40,756,568.80, due to increased personnel costs and consulting fees[15]. - Research and development expenses increased to approximately 90.12 million from 78.13 million, representing a growth of 15.4%[40]. - Financial expenses rose to approximately 75.31 million from 55.17 million, an increase of 36.5%[40]. - The tax expenses for the current period were approximately 45.32 million, down from 57.99 million, a decrease of 21.9%[40].